Karista invests in SamanTree - 3 questions to Amine Benmoussa

How would you describe SamanTree Medical? 

A disruptor in surgical oncology. SamanTree Medical is redefining real-time cancer-surgery imaging with its groundbreaking Histolog scanner. Already used in over 5,000 surgical procedures, the CE-marked and FDA-cleared device harnesses massive parallel confocal microscopy to deliver instant, high-resolution images of fresh tissue, giving surgeons the power to assess margins on the spot. No waiting, no guesswork, fewer re-ops and better outcomes!

What motivated your investment in SamanTree Medical?

We were particularly attracted by the transformative potential of SamanTree. The Histolog scanner solves a critical pain point in surgical oncology – the need for real-time, precise margin assessment. Traditional pathology methods take hours or even days, but with the Histolog scanner, surgeons get instant feedback, leading to fewer re-operations, more confident decisions, and better patient care. The technology is already proving its value in clinical settings, and we see it setting a new gold standard for intraoperative precision.

How does this investment fit in with Karista's philosophy?

To access the report, please fill out the form

Thank you! Redirecting you to the download page ...
Oops! Something went wrong while submitting the form. Please try again.